TRAT1 and cancer: In a clear contrast to the so-far described scenarios in which TRIM25 has been commonly shown as an oncogenic protein which can essentially contribute to chemoresistance of many human cancers, data from nasopharyngeal carcinoma (NPC) clearly imply an opposite role of this particular TRIM member.